Prevalence and Diagnostic Journey of Friedreich’s Ataxia in the State of São Paulo, Brazil
Tóm tắt
Friedreich's Ataxia (FRDA) is the leading cause of ataxia worldwide, but data on epidemiology and diagnostic journey are scarce, particularly in Latin America. Herein we estimated the prevalence of FRDA in the most populous Brazilian state and characterized the diagnostic odyssey of the disease. We received anonymized data of patients with FRDA from advocacy groups and physicians. Prevalence was estimated dividing the number of patients by the population of the state as reported in the last census. Patients were invited to answer an online survey to describe clinical data and diagnostic journey of the disease. FRDA estimated prevalence was 0.367:100,000, with a slight predominance of women (58.2% vs 41.7%). One hundred and four patients answered the survey (mean age of 37.3 ± 13.8 years; 75.9% classical and 24.0% late onset). On average, 6.2 ± 4.1 physicians were visited before reaching the diagnosis. Mean diagnostic delay was 7.8 ± 6.7 years; no difference between classical and LOFA groups was found. Most of the patients reported unsteadiness and gait abnormalities as the first symptom. Neurologists and orthopedical surgeons were the main specialties first sought by patients. We found a prevalence of 0.36:100,000 for FRDA in the state of São Paulo, Brazil. The disease is characterized by remarkable diagnostic delay, with no relevant differences between classical and LOFA patients.
Từ khóa
Tài liệu tham khảo
Pandolfo M. Friedreich ataxia. Arch Neurol. 2008;65:1296–303.
Ueber FN. Degenerative Atrophie der Spinalen Hinterstränge. Arch Pathol Anat Phys Klin Med. 1863;26:391–419.
Campuzano V, Montermini L, Moltò MD, Pianese L. Friedreich’s ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science. 1979;1996(7):271–1423.
Cook A, Giunti P. Friedreich’s ataxia: clinical features, pathogenesis and management. Br Med Bull. 2017;124:19–30 (Oxford University Press).
Martinez ARM, Moro A, Abrahao A, Faber I, Borges CR, Rezende TJR, et al. Nonneurological involvement in late-onset Friedreich Ataxia (LOFA): exploring the phenotypes. Cerebellum. 2017;16(1):253–6.
Buesch K, Zhang R. A systematic review of disease prevalence, health-related quality of life, and economic outcomes associated with Friedreich’s Ataxia. Curr Med Res Opin. 2022;38(10):1739–49.
Juvonen V, Kulmala SM, Ignatius J, Penttinen M, Savontaus ML. Dissecting the epidemiology of a trinucleotide repeat disease - Example of FRDA in Finland. Hum Genet. 2002;110(1):36–40.
Polo JM, Calleja J, Combarros O, Berciano J. Hereditary ataxias and paraplegias in Cantabria, Spain: an epidemiological and clinical study. Brain. 1991;114(2):855–66.
Carvalho-Silva DR, Santos FR, Rocha J, Pena SDJ. The phylogeography of Brazilian Y-Chromosome lineages. Am J Hum Genet. 2001;68(1):281–6.
Gonçalves VF, Carvalho CMB, Bortolini MC, Bydlowski SP, Pena SDJ. The phylogeography of African Brazilians. Hum Hered. 2007;65(1):23–32.
Fussiger H, Saraiva-Pereira ML, Leistner-Segal S, Jardim LB. Friedreich Ataxia: diagnostic yield and minimal frequency in South Brazil. Cerebellum. 2019;18(1):147–51.
https://www.ibge.gov.br/cidades-e-estados/sp/ [Internet]. [cited 2023 Nov 1]. IBGE website. Available from: https://www.ibge.gov.br/cidades-e-estados/sp/. Accessed 12 Nov 2023.
Smith DC, Greenberg LJ, Bryer A. The hereditary ataxias: where are we now? Four decades of local research. S Afr Med J. 2016;106(6):S38-41.
Sasaki H, Yabe I, Yamashita I, Tashiro K. Prevalence of triplet repeat expansion in ataxia patients from Hokkaido, the northernmost island of Japan [Internet]. J Neurol Sci. 2000;175(1):45–51. https://www.elsevier.com/locate/jns. Accessed 12 Nov 2023.
Vankan P. Prevalence gradients of Friedreich’s Ataxia and R1b haplotype in Europe co-localize, suggesting a common Palaeolithic origin in the Franco-Cantabrian ice age refuge. J Neurochem. 2013;126:11–20 (Blackwell Publishing Ltd).
Koutsis G, Kladi A, Karadima G, Houlden H, Wood NW, Christodoulou K, et al. Friedreich’s ataxia and other hereditary ataxias in Greece: an 18-year perspective. J Neurol Sci. 2014;336(1–2):87–92.
Zortea M, Armani M, Pastorello E, Nunez GF, Lombardi S, Tonello S, et al. Prevalence of inherited ataxias in the province of Padua, Italy. Neuroepidemiology. 2004;23:275–80.
Lynch DR, Schadt K, Kichula E, McCormack S, Lin KY. Friedreich ataxia: Multidisciplinary clinical care. J Multidiscip Healthc. 2021;14:1645–58 (Dove Medical Press Ltd).
Mariño TC, Zaldivar YG, Mesa JML, Mederos LA, Rodríguez RA, Gotay DA, et al. Low predisposition to instability of the Friedreich ataxia gene in Cuban population. Clin Genet. 2010;77:598–600.
Hilbert JE, Ashizawa T, Day JW, Luebbe EA, Martens WB, McDermott MP, et al. Diagnostic odyssey of patients with myotonic dystrophy. J Neurol. 2013;260(10):2497–504.
Indelicato E, Nachbauer W, Eigentler A, Amprosi M, Matteucci Gothe R, Giunti P, et al. Onset features and time to diagnosis in Friedreich’s Ataxia. Orphanet J Rare Dis. 2020;15(1):198.
Reetz K, Dogan I, Costa AS, Dafotakis M, Fedosov K, Giunti P, et al. Biological and clinical characteristics of the European Friedreich’s Ataxia Consortium for Translational Studies (EFACTS) cohort: A cross-sectional analysis of baseline data. Lancet Neurol. 2015;14(2):174–82.
Giunti P, Greenfield J, Stevenson AJ, Parkinson MH, Hartmann JL, Sandtmann R, et al. Impact of Friedreich’s Ataxia on health-care resource utilization in the United Kingdom and Germany. Orphanet J Rare Dis. 2013;8(1):38.